Dendritic Cells in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation
NCT00450268 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2007-03-22
Summary
We plan to investigate prospectively and simultaneously skin and blood DC subtypes, their donor/recipient origin and the correlation of DC reconstitution kinetics with treatment, clinical outcome and incidence of aGvHD in patients undergoing allogeneic hematopoietic stem cell transplantation.
Conditions
Interventions
- PROCEDURE
-
blood draw, skin shave biopsy
Sponsors & Collaborators
-
Technische Universität Dresden
lead OTHER
Principal Investigators
-
Susanne Gretzinger, MD · Universität Carl Gustav Carus Med Klinik I
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-01-31
- Completion
- 2010-01-31
Countries
- Germany
Study Locations
More Related Trials
-
Transplant T CD4+ CCR7+ In Hematopoietic Stem Cells Allograft
NCT03280290 ·Status: COMPLETED ·Phase: NA
-
Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant
NCT00725062 ·Status: TERMINATED ·Phase: PHASE1
-
National Marrow Donor Program Long-Term Donor Follow-Up
NCT01362179 ·Status: COMPLETED
-
The Skin Microbiome in Graft Versus Host Disease
NCT04231500 ·Status: ACTIVE_NOT_RECRUITING
-
DSAs in Patients Undergoing Allo-HSCT From Mismatched Donors
NCT04888286 ·Status: COMPLETED
-
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
NCT06856226 ·Status: RECRUITING
-
Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR
NCT01611298 ·Status: COMPLETED ·Phase: NA
-
Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly Patients
NCT02623309 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202)
NCT01879072 ·Status: COMPLETED
-
Preemptive Infusion of Donor Lymphocytes Depleted of TCR + T Cells + CD19+ B Cells Following ASCT
NCT03939585 ·Status: WITHDRAWN ·Phase: PHASE1
-
Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study
NCT03086252 ·Status: WITHDRAWN ·Phase: NA
-
Conditioning Regimen Before Infusion of Allogeneic Hematopoietic Stem Cells
NCT00770523 ·Status: COMPLETED
-
Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell Transplantation
NCT07235501 ·Status: NOT_YET_RECRUITING
-
Analysis of T-Cell Immune Reconstitution Following Allogeneic Hematopoietic BMT for Severe SCD
NCT00228631 ·Status: COMPLETED
-
Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant
NCT00900406 ·Status: COMPLETED
-
Donor Neutrophil Subsets to Predict the Risk of aGVHD
NCT06394895 ·Status: ACTIVE_NOT_RECRUITING
-
Home Blood Transfusions
NCT07121140 ·Status: RECRUITING ·Phase: NA
-
Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia
NCT00001623 ·Status: COMPLETED ·Phase: NA
-
Role of aGVHD Biomarkers on aGVHD Risks
NCT04284904 ·Status: COMPLETED
-
Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases
NCT06294691 ·Status: RECRUITING ·Phase: PHASE3
-
Kinectics of Donor-specific Anti-HLA Antibody After HLA-incompatible Allogeneic Haematopoietic Stem Cell Transplantation
NCT06395220 ·Status: COMPLETED
-
Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes
NCT00001405 ·Status: RECRUITING
-
Study of the Complications Associated With Certain Stem Cell Transplants
NCT01919099 ·Status: COMPLETED
-
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
NCT01206309 ·Status: COMPLETED
-
Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
NCT00003538 ·Status: COMPLETED ·Phase: NA